Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

December 18th 2025, 1:06am

By Ryan Scott

The FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer.

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

December 17th 2025, 10:00pm

By Alex Biese

Actor Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

December 17th 2025, 8:18pm

By Alex Biese

The FDA granted regular approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer.

Education and Inspiration Across the Cancer Journey

December 17th 2025, 8:00pm

By Mike Hennessy Jr.

At CURE, we strive to provide insight, education and inspiration for patients, survivors and caregivers at every stage of the cancer journey.

Testicular Cancer Survivor Shares Story of Courage in New Book

December 17th 2025, 6:00pm

By Alex Biese

CURE contributor Brian Sluga discusses his new memoir, “The Shriek I Do Remember.”

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

December 17th 2025, 5:00pm

By Ryan Scott

Padcev plus Keytruda demonstrated clinically meaningful and statistically significant improvements in event-free survival and overall survival for MIBC.

GSK’227 Wins FDA Orphan Drug Designation in Small-Cell Lung Cancer

December 17th 2025, 4:00pm

By Ryan Scott

The FDA granted orphan drug designation to GSK’227, now known as risvutatug rezetecan, for the treatment of small-cell lung cancer.

Delayed Diagnoses of CSCC in People of Color: The Hidden Risk of Detection at Advanced Stages

December 17th 2025, 2:17pm

A Patient’s Journey Through Remission and Mental Health With Non-Hodgkin Lymphoma

December 17th 2025, 2:00pm

By Jace Yawnick

Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.

Key Blood Cancer Advances for Patients From the 2025 ASH Annual Meeting

December 16th 2025, 10:00pm

By Ryan Scott

At the 2025 ASH Annual Meeting and Exposition, researchers presented new findings that may meaningfully affect how patients with blood cancers are treated.

Expert Explains Nutrition and Weight Loss Challenges in Gastric Cancer

December 16th 2025, 9:00pm

By Raghav Sundar, M.B.B.S., M.R.C.P., M.Med.

Gastric cancer care highlights eating difficulties, weight loss and side effects showing why nutrition support and clinical trials are key

When Chemotherapy Side Effects Sent Her to the ICU

December 16th 2025, 8:00pm

By Lindsey Gunter

After beginning treatment for stage 3 inflammatory breast cancer, Lindsey Gunter started experiencing chemotherapy side effects so intense she was unable to walk.

Navigating the Holidays When Cancer Never Quite Leaves

December 16th 2025, 6:00pm

By Linda Cohen

Living with chronic cancer means navigating the holidays with extra caution — but also with deeper gratitude for every moment I’m able to show up.

SHARON Trial Offers a Potential Approach for Advanced Pancreatic Cancer

December 16th 2025, 5:03pm

By Ryan Scott

A potential new approach to treating advanced pancreatic cancer has shown benefit for patients, according to Dr. Eileen M. O'Reilly.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

December 16th 2025, 4:00pm

By Spencer Feldman

The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases.